Hosted on MSN2mon
Metsera raises $215m in Series B round for weight loss candidatesDespite the competitive nature for funding in the crowded weight loss treatment space, Metsera has won $215m to advance its glucagon-like peptide-1 receptor agonist (GLP-1RA) orientated portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback